Partnering for Success

Your drug is an asset. Protect it by investing wisely in an outsource partner who values your work as much as you do. If cutting edge technologies, regulatory experience, and a collaborative team who knows just what it takes to get your drug to market seems expensive, consider the cost of poorly executed studies, missed milestones and an inefficient approach to development.

two scientists

We’re with you, every step of the way.


It’s impossible to anticipate the challenges you’ll face on the journey to market. Your best asset is a nimble, versatile nonclinical partner who knows how to scale scientific hurdles, overcome regulatory snags, and clear a path to approval.

Combining all the advantages of a world-leading CRO with flexible, responsive service and programs tailored to your molecule, whether it's a human or veterinary drug, an agro- or industrial chemical, or a food additive, Charles River delivers.

  • Move seamlessly from Discovery to the Clinic with the personal attention and dedication of our Scientific Advisory Services.
  • Access the industry’s most comprehensive portfolio for custom solutions that get results. We’ll help you successfully initiate and complete your clinical trial-enabling program and subsequent nonclinical studies through Post Marketing or the nonclinical studies you need to have done for registration with/for EPA, REACH, or other international Agencies.

 

IND e-guide graphic
OUR INVESTIGATIONAL NEW DRUG DEVELOPMENT PROGRAMS EGUIDE

Evolving market pressures are changing the focus of the drug development industry, further accelerating early phases in order to create late-stage pipeline growth.

Download our IND eGuide to understand how and when to plan your preclinical IND-enabling program as an integral part of meeting specific milestones necessary to timely and efficient IND submission.

Download the eGuide

 

 

Toxicologist in the lab